You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Tools and Methods for Producing High Quality Functional Protein Microarrays for Biomarker Discovery

    SBC: SPOC PROTEOMICS INC.            Topic: 100

    Abstract ProjectAdministrative Supplements to projectTools and Methods for Producing HighQuality Functional Protein Microarrays for Biomarker Discovery INanoBio is developing ProCap system capable of semi automated production of functional protein arrayswhich can be phosphorylatedde phosphorylated by kinasesphosphatases in high throughput formatin addition to other PTM modificationsAs described in ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  2. Human on a chip system to investigate genetic risk factors in Alzheimer's disease

    SBC: HESPEROS, INC            Topic: NIA

    Project Summary AbstractHesperos will construct and test microscale multi organ systems with recirculating blood and cerebral spinal fluid surrogates that will give insights to the responses of various Alzheimer s phenotypes to drugs as well as the influence of peripheral effects on AD progressionspecifically ApoE variantsWe seek to leverage DrMorgan s research on Alzheimer s and aging combine it ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  3. SMART: A Breath-based Adherence Technology to Monitor HIV Microbicide Gel Use

    SBC: XHALE, INC.            Topic: 105

    DESCRIPTION provided by applicant In HIV pre exposure prophylaxis PrEP trials sub optimal oral and microbicide adherence has precluded accurate estimation of drug efficacy Measurement of adherence is a major unmet challenge Other objective measures of adherence in microbicide trials have been tested but none measure the actual use of the product We propose to rapidly develop an alternati ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Lab-To-Marketplace: Commercialization of a stretchable microelectrode array

    SBC: BMSEED LLC            Topic: 101

    DESCRIPTION provided by applicant The proposed work is directed at the commercialization of a stretchable microelectrode array BMSEEDandapos s sMEA a new tool that provides enhanced capabilities to simultaneously interface mechanically and electrically with cell cultures in vitro The mechanical stretching of neurons in the brain or spinal cord is often te root cause of traumatic brain injur ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria

    SBC: VisionQuest Biomedical Inc            Topic: NIAID

    DESCRIPTION provided by applicant VisionQuest Biomedical and its collaborators have assembled a team of inter disciplinary scientists with considerable experience in automated retinal image analysis clinical ophthalmology with specialized research in malarial retinopathy MR and cerebral malaria diagnosis CM This team will develop and test an automated MR screening software system integra ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Human on a chip systems to investigate disease comorbidities common in the aged population

    SBC: HESPEROS, INC            Topic: NIA

    Project SummaryBoth older adults and the pharmaceutical industry would benefit from the development of human on a chip systems to be able to systematically investigate disease comorbidities and their response to drug candidates in the aged population at the preclinical stage due to the lack of good multimodal models of disease combinationsWe will investigate diseases that are most prevalent in the ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  7. DEVELOPMENT OF A PEDIATRIC CARDIAC AND RESPIRATORY ASSIST SYSTEM

    SBC: INSPIRED THERAPEUTICS LLC            Topic: NHLBI

    Inspired TherapeuticsMerritt Island FLis developing a simplecost effectivemechanical circulatory supportMCSsystemINSPIRETMdesigned as a single driver with interchangeable pumps for multiple pediatric and adult cardiopulmonary indications and operational settingsThe goal of this phase I study is to continue development and demonstrate feasibility for pediatric left ventricular assist deviceLVADsupp ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  8. A mobile framework to measure ejection fraction by automated non-invasive analysi

    SBC: AVENTUSOFT L.L.C.            Topic: 102

    DESCRIPTION provided by applicant This SBIR Phase I project will develop a novel mobile framework to measure left ventricular ejection fraction as a marker for systolic dysfunction using automated non invasive analysis of cardiac signals Heart disease is the leading cause of death for men and women accounting for more than one third of all U S deaths In total costs associated w ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Mobile multifunctional tool for monitoring and management of respiratory diseases

    SBC: TF HEALTH CORPORATION            Topic: NHLBI

    DESCRIPTION (provided by applicant): Mobile multifunctional tool for monitoring and management of respiratory diseases Chronic Obstructive Pulmonary Disease (COPD) and asthma affect millions of people worldwide. Because there is no permanent cure for thesediseases, efficient management of the patients over their entire lifetime are needed, which becomes increasingly difficult with the rapid rise i ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. GAA-ITEM: Personalizing the Prediction of Anti-therapeutic Antibody Response in Pompe Disease Patients

    SBC: EPIVAX, INC.            Topic: 999

    Abstract SignificanceInfantile Pompe DiseaseIPDis an autosomal recessive glycogen storage disorder caused by a deficiency of acid alpha glucosidaseGAAleading to accumulation of glycogen in lysosomesprimarily in skeletalcardiac and smooth musclesUntreated IPD infants die within the firstyears of lifeEnzyme replacement therapyERTwith recombinant human GAArhGAAimproves survival and quality of lifebut ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government